Patients affected by Eosinophilic Granulomatosis with Polyangiitis (EGPA) display an increased risk of atherothrombotic events compared with the general population. An increased frequency of subclinical markers of atherosclerosis has been observed in other anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), but no specific study focused on EGPA. We therefore evaluated subclinical atherosclerosis in EGPA patients and in a control population.
